Veridian Expands Respiratory Device Portfolio with Acquisition of Zewa
The acquisition strengthens Veridian Healthcare’s respiratory device offerings and expands its remote patient monitoring and telehealth product portfolio.
The acquisition strengthens Veridian Healthcare’s respiratory device offerings and expands its remote patient monitoring and telehealth product portfolio.
mRNA encoding immunomodulatory proteins IκBα-SR and SOD3 ameliorated symptoms in a bacterial pneumonia model.
The Vitalograph AIM (Aerosol Inhalation Monitor) is designed to assist medical practitioners in training patients to use their inhalers correctly.
Nebulized magnesium with albuterol does not significantly decrease the hospitalization rate of children who present at the emergency department for asthma.
Read MoreAsthma patients using Propeller Health experienced a significant decline in rescue inhaler use and higher medication adherence rates compared to patients not using the platform.
Read MoreTezepelumab is an effective therapy for severe asthma in patients with and without allergies, a new study found.
Read MoreAsthma patients in the US who use biologic therapies don’t often switch from one biologic therapy to another, according to data from a recent study.
Read MoreA report from Smithsonian Magazine explores the origin story of the asthma inhaler.
Read MoreAn automatic, electronic alert on general practitioners’ computer screens can help to prevent excessive prescribing of short-acting asthma reliever medication, according to research presented at the virtual European Respiratory Society International Congress.
Read MoreResponse to inhaled corticosteroids in individuals with newly diagnosed asthma may be predicted by high blood and sputum eosinophil counts, according to a new study.
Read MoreA new study shows that chronic obstructive pulmonary disease (COPD) patients may experience the strongest benefits from single-inhaler therapy.
Read MoreResearchers believe the COVID-19 pandemic may have influenced increases in medication adherence for patients with asthma and COPD between January and March 2020.
Read MoreResearch into common asthma aerosol treatments could improve therapeutics in the future, according to a study published in European Journal of Pharmaceutics and Biopharmaceutics.
Read MoreThe US FDA has approved the first generic metered dose inhaler of Proventil HFA (albuterol sulfate), manufactured by Cipla Ltd.
Read MoreAs the number of COVID-19 cases grow, hospitals throughout the US are reporting shortages of albuterol, a life saving medication for asthma sufferers.
Read More